Opaleye Management Inc. bought 3,087 shares of Grace Therapeutics, Inc. at $1.77 for $5.48k on Nov 5, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
10% owner
10%
Filed Nov 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$5,478.19Shares × reported price
Shares traded
3,087Common Stock, par value $0.0001 per share
Price per share
$1.77Reported price. Read footnotes for ranges.
% of reported position traded
0.1%This security and ownership context
Holdings after
3,054,853Indirect · By Opaleye, L.P.
Trade date
Nov 5, 2026Buy
Filed
Nov 5, 2026, 9:05 PM ET1-day reporting delay
Accession
0001493152-26-050313Code P · Transaction 394215
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 3,051,766 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 3, 2026Buy10,328$1.79$18,480.92Trade 394213
Nov 4, 2026Buy5,027$1.80$9,060.16Trade 394214
3 transaction rows in this filing. Joint filers share the same rows.

GRCE price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
GRCE · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +11%1w ago +4.9%1d ago −2.2%
Returns since7d −2.2%30d90d180d1y

Footnotes in full

F1: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. F2: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.775 to $1.79. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range. F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.80 to $1.81. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range. F4: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.77 to $1.78. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range. F5: Opaleye Management Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.